Results 231 to 240 of about 154,358 (318)

SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices

open access: yesESC Heart Failure, EarlyView.
Abstract Background Sodium glucose cotransporter 2 inhibitors (SGLT2i) represent one of the four pillars of heart failure (HF) pharmacological therapy. Objective The study aims to clarify SGLT2i antiarrhythmic effect on patients with HF with reduced ejection fraction (HFrEF) in terms of atrial and ventricular arrhythmias (AAs and VAs) reduction ...
Marco Valerio Mariani   +17 more
wiley   +1 more source

Validation of a biomarker‐based mortality score for cardiogenic shock patients: Comparison with a clinical risk score

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Cardiogenic shock (CS) is the deadliest manifestation of acute heart failure, with persistently high mortality rates and a lack of recent therapeutic breakthroughs. Accurate risk prediction is crucial in clinical decision‐making and the design of future clinical trials.
Elina Hynninen   +14 more
wiley   +1 more source

Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL.
Matteo Pagnesi   +21 more
wiley   +1 more source

Cardiac Arrhythmias during Halothane Anesthesia

open access: bronze, 1968
P. E. VANIK, Hamilton S. Davis
openalex   +1 more source

Right ventricular dysfunction for prediction of long‐term recovery in de novo HFrEF : a PROLONG‐II substudy

open access: yesESC Heart Failure, EarlyView.
Abstract Aims To analyse the predictive value of advanced markers of right ventricular (RV) function and RV‐pulmonary arterial (PA) coupling in forecasting long‐term left ventricular (LV) improvement in de novo heart failure with reduced ejection fraction (HFrEF).
Aiste Monika Jakstaite   +10 more
wiley   +1 more source

Cardiac magnetic resonance left atrioventricular coupling index as a prognostic tool in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Abstract Aims A novel marker left atrioventricular coupling index (LACI) has been proved to be associated with cardiovascular events in patients without history of cardiovascular disease. However, the studies on cardiac magnetic resonance‐derived LACI in hypertrophic cardiomyopathy (HCM) patients are limited, and the prognostic value of LACI has still ...
Jinyang Wen   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy